GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Price-to-Tangible-Book

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Price-to-Tangible-Book : 27.51 (As of May. 14, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Price-to-Tangible-Book?

As of today (2025-05-14), Beijing Bohui Innovation Biotechnology Group Co's share price is ¥5.86. Beijing Bohui Innovation Biotechnology Group Co's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was ¥0.21. Hence, Beijing Bohui Innovation Biotechnology Group Co's Price to Tangible Book Ratio of today is 27.51.

The historical rank and industry rank for Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300318' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 10.84   Med: 20.97   Max: 1035
Current: 27.9

During the past 13 years, Beijing Bohui Innovation Biotechnology Group Co's highest Price to Tangible Book Ratio was 1035.00. The lowest was 10.84. And the median was 20.97.

SZSE:300318's Price-to-Tangible-Book is ranked worse than
95.58% of 1199 companies
in the Biotechnology industry
Industry Median: 2.61 vs SZSE:300318: 27.90

A closely related ratio is called PB Ratio. As of today, Beijing Bohui Innovation Biotechnology Group Co's share price is ¥5.86. Beijing Bohui Innovation Biotechnology Group Co's Book Value per Sharefor the quarter that ended in Mar. 2025 was ¥1.68. Hence, Beijing Bohui Innovation Biotechnology Group Co's P/B Ratio of today is 3.48.


Beijing Bohui Innovation Biotechnology Group Co Price-to-Tangible-Book Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Price-to-Tangible-Book Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 18.34 21.30 25.88

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.97 18.07 22.90 25.88 25.82

Competitive Comparison of Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book falls into.


;
;

Beijing Bohui Innovation Biotechnology Group Co Price-to-Tangible-Book Calculation

Beijing Bohui Innovation Biotechnology Group Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=5.86/0.213
=27.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Beijing Bohui Innovation Biotechnology Group Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Executives
Niu Shu Hui Executives
Di Xiao Feng Director
Yang Qi Director
Lu Xin Qun Directors, executives
Zhang Lei Director
Wan Zhang Geng Executives
Song Rui Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines